Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.41 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | G6PD | P11413 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1005104 | 0.88 | PABPC1 (0.39) | PABPC1APOBEC3AAPOBEC3GALDH1A1LMNA | |
| SCHEMBL410781 | 0.88 | ALDH1A1 (0.44) | ALDH1A1LMNAKMT2ACHRM2CHRM1 | |
| SCHEMBL25501673 | 0.86 | ALDH1A1 (0.38) | PABPC1APOBEC3AAPOBEC3GALDH1A1LMNA | |
| SCHEMBL13846311 | 0.86 | LMNA (0.34) | PABPC1APOBEC3AAPOBEC3GALDH1A1LMNA | |
| SCHEMBL29786589 | 0.85 | THRB (0.36) | PABPC1APOBEC3AAPOBEC3GALDH1A1LMNA | |
| SCHEMBL3366978 | 0.85 | KMT2A (0.40) | PABPC1APOBEC3AAPOBEC3GALDH1A1LMNA | |
| SCHEMBL19834253 | 0.84 | LMNA (0.33) | PABPC1APOBEC3AAPOBEC3GALDH1A1LMNA | |
| SCHEMBL12284960 | 0.83 | CHRM1 (0.35) | PABPC1APOBEC3AAPOBEC3GALDH1A1LMNA | |
| SCHEMBL12285117 | 0.83 | CHRM1 (0.35) | PABPC1APOBEC3AAPOBEC3GALDH1A1LMNA | |
| SCHEMBL7781984 | 0.82 | OPRM1 (0.32) | PABPC1APOBEC3AAPOBEC3GKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10414847-B2 | Polymer brush | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2019-09-17 | — | — | US | disclosed |
| US-20170152339-A1 | POLYMER BRUSH | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2017-06-01 | — | — | US | disclosed |
| US-7652084-B2 | alkene modified; enhanced mechanical and electrical properties, especially elongation-to-break ratio and the toughness of fibers and/or films | The Reseach Foundation of State University of New York (US) | 2010-01-26 | — | — | US | disclosed |
| US-20080275177-A1 | Nanocomposite Fibers and Film Containing Polyolefin and Surface-Modified Carbon Nanotubes | NATIONAL SCIENCE FOUNDATION | 2008-11-06 | — | — | US | disclosed |
| US-7402675-B2 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-07-22 | — | — | US | disclosed |
| US-6900328-B2 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-05-31 | — | — | US | disclosed |
| US-20050043552-A1 | Process for the synthesis of amine ethers from secondary amino oxides | HAFNER ANDREAS (CH) | 2005-02-24 | — | — | US | disclosed |
| US-20030171461-A1 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORP. | 2003-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043552-A1 | Process for the synthesis of amine ethers from secondary amino oxides | CYC1, AOC2, CBR1 | PABPC1 4030/4885APOBEC3A 2557/4885APOBEC3G 3122/4885 |
| US-20030171461-A1 | Process for the synthesis of amine ethers from secondary amino oxides | IL4I1, HCCS, CBR1 | PABPC1 2578/4885APOBEC3A 2287/4885APOBEC3G 2220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.